Allstate Corporation’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.65M Sell
21,401
-317
-1% -$23.1K 0.02% 553
2026
Q1
$1.42M Buy
21,718
+10,436
+93% +$775K 0.02% 665
2025
Q4
$894K Buy
11,282
+5,780
+105% +$443K 0.01% 538
2025
Q3
$402K Buy
+5,502
New +$403K 0.01% 552
2025
Q2
Sell
-6,478
Closed -$493K 585
2025
Q1
$493K Buy
6,478
+2,120
+49% +$158K 0.01% 506
2024
Q4
$288K Buy
+4,358
New +$305K 0.01% 587

Other funds holding SOLV

Allstate Corporation's SOLV Position: Q2 2026 in Review

Allstate Corporation reduced its Solventum (SOLV) stake by 1.5% in Q2 2026, selling an estimated $23.1K and leaving 21,401 shares worth $1.65M. The position accounts for 0.02% of the portfolio, ranked #553.

Allstate Corporation first reported a position in SOLV in Q4 2024 and has held it in 6 quarters since. 883 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • Allstate Corporation held 21,401 shares of Solventum worth $1.65M as of Q2 2026.
  • Allstate Corporation sold 317 Solventum shares in Q2 2026, an estimated $23.1K.
  • Solventum made up 0.02% of Allstate Corporation's portfolio in Q2 2026, its #553 holding.
  • Allstate Corporation first reported a position in Solventum in Q4 2024 and has held it in 6 quarters since.
  • 883 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.